Directly Compressible Carrier for Lipophilic Ingredients
Building on decades of excipient co-processing know-how, the newest member of the PROSOLV® family, PROSOLV® 730, was developed. It provides solutions to challenges presented by oily active ingredients and poorly water-soluble, lipophilic substances.
PROSOLV® 730 has multiple advantages for both nutraceutical and pharmaceutical formulations:
Adsorption and direct compression of oils
Conversion of soft-gel capsules into tablets
Dissolution enhancement of lipophilic actives
Modified release of lipophilic actives
What is PROSOLV® 730?
PROSOLV® 730 is a co-processed composite made from microcrystalline cellulose, silicon dioxide, and copovidone. Each component complies with the corresponding monographs of the Ph. Eur and USP/NF and is safe for nutraceutical applications.
Physical Properties of PROSOLV® 730:
High oil binding capacity
White, free-flowing powder
Chemically inert
Non soluble
Excellent compactability
Enhanced lubrication efficiency
Improved blending properties
Over 70 times greater specific surface area than regular Microcrystalline Cellulose (MCC)
Co-processed excipient with no chemical bonding between ingredients